Cargando…
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study
BACKGROUND: Acute severe ulcerative colitis (ASUC) is a potentially life-threatening disease, and the best option in cases of steroid-refractory disease is still debated. We compared the early- and long-term efficacy and safety of the 2 available “rescue therapies”, infliximab (IFX) and cyclosporine...
Autores principales: | Grazie, Marco Le, Bagnoli, Siro, Dragoni, Gabriele, Caini, Saverio, Annese, Vito, Innocenti, Tommaso, Deiana, Simona, Manetti, Natalia, Milani, Stefano, Galli, Andrea, Milla, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079874/ https://www.ncbi.nlm.nih.gov/pubmed/33948062 http://dx.doi.org/10.20524/aog.2021.0584 |
Ejemplares similares
-
Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?
por: Vecchi, Maurizio, et al.
Publicado: (2013) -
Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020) -
Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis
por: Chapman, Christopher G., et al.
Publicado: (2014) -
Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022) -
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey
por: Innocenti, Tommaso, et al.
Publicado: (2022)